Search
for
Sort by
Research 241–270 of 537
- Incidence of alopecia from endocrine therapies in cancer
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- Onychomatricoma with classic features: Case report and review of the literature
- Polycystic Ovary Syndrome and Oxidative Stress—From Bench to Bedside
- The First Visit: Consult and Workup Before Sperm Banking
- Serum Adiponectin and Leptin in Patients with Alopecia Areata
- Anti-Androgen Drugs in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review
- Increased Prevalence of Insulin Resistance and Metabolic Syndrome in Men With Early‐Onset Androgenetic Alopecia: A Case–Control Study
- The value of the free androgen index depends on the phenotype of polycystic ovary syndrome — a single-centre experience
- Predictors of insulin resistance among women with acne vulgaris and polycystic ovarian syndrome presenting to a tertiary care hospital in North India
- Exploring the Clinical and Investigational Profile of Females With Hirsutism at a Tertiary Care Center
- Concentrations of Chromium, Selenium, and Copper in the hair of visceral-obese adults are associated with insulin resistance
- Association of insulin resistance with polycystic ovary syndrome phenotypes and patients’ characteristics: a cross-sectional study in Iran
- Factors associated with premature hair graying in a young Indian population
- Postmenopausal ovarian hyperandrogenism of surgically treated patients: a case report and scoping review with individual patient’s data analysis
- A Study of Prevalence of Metabolic Syndrome in Premenopausal Women With Female Pattern Hair Loss: A Case-Control Study
- Plasma Diaphanous Related Formin 1 Levels Are Associated with Altered Glucose Metabolism and Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Case Control Study
- Dunnigan-Type Familial Partial Lipodystrophy: Understanding and Treating the Syndrome
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making
- Evaluation of Serum Level of Zinc Alpha 2 Glycoprotein in Male Patients with Androgenetic Alopecia
- Defective Expression of the Gap Junction Protein Pannexin-1 Channel Contributes to the Formation of PCOS-Realted Androgenetic Alopecia
- Gonadal profile in men with early-onset androgenetic alopecia: does a male PCOS-equivalent syndrome exist?
- The effects of pro-, pre- and synbiotics supplementation on polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials
- Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- Metabolic syndrome in androgenic alopecia